The Functional Impact of Alternative Splicing in Cancer

Héctor Climente-González1, Eduard Porta-Pardo2, Adam Godzik3

  • 1Computational RNA Biology Group, Pompeu Fabra University (UPF), 08003 Barcelona, Spain; MINES ParisTech, PSL-Research University, CBIO-Centre for Computational Biology, 77300 Fontainebleau, France; Institut Curie, 75248 Paris Cedex, France; INSERM U900, 75248 Paris Cedex, France.

Cell Reports
|August 31, 2017
PubMed

Insights

Alternative splicing changes in cancer may drive tumor development independently of traditional mutations. Some splicing alterations could act as novel cancer drivers, offering new therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Alternative splicing alterations are common in cancer and are emerging as significant indicators of tumor progression and treatment response.
  • The functional implications and direct role of these splicing changes in tumorigenesis are not yet fully understood.

Purpose of the Study:

  • To systematically analyze the functional consequences of alternative splicing changes across numerous cancer types.
  • To investigate the relationship between alternative splicing events and somatic mutations in cancer driver genes.

Main Methods:

  • Performed a large-scale computational analysis of alternative splicing patterns in thousands of tumor samples.
  • Examined the overlap between alternatively spliced protein domains and frequently mutated domains in cancer.
  • Assessed correlations between alternative splicing events and somatic mutations in known cancer drivers.

Main Results:

  • Identified a subset of alternative splicing changes impacting protein domains frequently mutated in cancer.
  • These splicing alterations may disrupt protein-protein interactions within cancer-related pathways.
  • Observed a negative correlation between the prevalence of specific alternative splicing changes and the number of somatic mutations in driver genes.

Conclusions:

  • A portion of observed alternative splicing changes in tumors may represent independent oncogenic processes contributing to cancer development.
  • These findings suggest that some alternative splicing events could function as novel "alternative splicing drivers" (AS drivers).
  • This highlights the potential of AS events as crucial factors in cancer functional transformations and as potential therapeutic targets.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.8K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.4K
Alternative RNA Splicing02:18

Alternative RNA Splicing

5.3K
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
8.3K
What is Gene Expression?01:36

What is Gene Expression?

A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is comprised  of nucleotides and proteins are comprised of amino acids, a mediator is required to convert the information encoded in DNA into proteins. This mediator is the messenger RNA (mRNA). mRNA copies the blueprint from DNA by a process called transcription. In eukaryotes, transcription occurs in the nucleus by complementary base-pairing with the DNA template. The mRNA is then...
11.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K